Midstream Health secured $20 million in Series A funding to provide health systems with additional financial stability. The round was led by Valtruis and included participation from Andreessen Horowitz (a16z), Foundry, and CommonSpirit Ventures. The startup’s pitch centers on improving how hospitals manage financial risk, which can become acute during payer swings, reimbursement delays, and operational pressures. The investment comes from major venture and healthcare-aligned investors, signaling that financial infrastructure and care delivery economics remain active areas for capital. For biotech-adjacent stakeholders, the development is a reminder that healthcare innovation funding is extending beyond drug discovery into the mechanisms that affect provider capacity and cash flow.